Seguir
KH Assi
KH Assi
School of Pharmacy and Medical Sciences, University of Bradford
E-mail confirmado em bradford.ac.uk - Página inicial
Título
Citado por
Citado por
Ano
Can all patients with COPD use the correct inhalation flow with all inhalers and does training help?
RAM Al-Showair, WY Tarsin, KH Assi, SB Pearson, H Chrystyn
Respiratory medicine 101 (11), 2395-2401, 2007
2822007
Emitted dose estimates from Seretide® Diskus® and Symbicort® Turbuhaler® following inhalation by severe asthmatics
WY Tarsin, SB Pearson, KH Assi, H Chrystyn
International journal of pharmaceutics 316 (1-2), 131-137, 2006
1022006
In-Vitro Intra- and Inter-Inhaler Flow Rate-Dependent Dosage Emission from a Combination of Budesonide and Eformoterol in a Dry Powder Inhaler
W Tarsin, KH Assi, H Chrystyn
Journal of aerosol medicine 17 (1), 25-32, 2004
952004
Microemulsion high performance liquid chromatography (MELC) method for the determination of terbutaline in pharmaceutical preparation
MS Althanyan, KH Assi, BJ Clark, J Hanaee
Journal of pharmaceutical and biomedical analysis 55 (3), 397-402, 2011
542011
Development and validation of HPLC method for the determination of tobramycin in urine samples post-inhalation using pre-column derivatisation with fluorescein isothiocyanate
M Mashat, H Chrystyn, BJ Clark, KH Assi
Journal of Chromatography B 869 (1-2), 59-66, 2008
532008
Dose emission and aerodynamic characterization of the terbutaline sulphate dose emitted from a Turbuhaler at low inhalation flow
ME Abdelrahim, KH Assi, H Chrystyn
Pharmaceutical development and technology 18 (4), 944-949, 2013
492013
Relative bioavailability of terbutaline to the lung following inhalation, using urinary excretion
ME Abdelrahim, KH Assi, H Chrystyn
British journal of clinical pharmacology 71 (4), 608-610, 2011
462011
High performance liquid chromatography assay method for simultaneous quantitation of formoterol and budesonide in Symbicort Turbuhaler
KH Assi, W Tarsin, H Chrystyn
Journal of pharmaceutical and biomedical analysis 41 (1), 325-328, 2006
452006
Aerodynamic characteristics of a dry powder inhaler at low inhalation flows using a mixing inlet with an Andersen Cascade Impactor
DK Nadarassan, KH Assi, H Chrystyn
European journal of pharmaceutical sciences 39 (5), 348-354, 2010
412010
Smart nanocrystals of artemether: fabrication, characterization, and comparative in vitro and in vivo antimalarial evaluation
SMH Shah, F Ullah, S Khan, SMM Shah, M de Matas, Z Hussain, ...
Drug design, development and therapy, 3837-3850, 2016
382016
Determination of organic acid drug counter-ions by capillary electrophoresis
KD Altria, KH Assi, SM Bryant, BJ Clark
Chromatographia 44, 367-371, 1997
371997
Determination of trace enantiomeric impurities in chiral compounds by capillary electrophoresis with uncoated, cationic, anionic and neutral surface modified capillaries
KH Assi, AM Abushoffa, KD Altria, BJ Clark
Journal of Chromatography A 817 (1-2), 83-90, 1998
351998
Validation of high-performance liquid chromatography assay for quantification of formoterol in urine samples after inhalation using UV detection technique
DK Nadarassan, H Chrystyn, BJ Clark, KH Assi
Journal of Chromatography B 850 (1-2), 31-37, 2007
332007
Development and evaluation of nanoemulsion and microsuspension formulations of curcuminoids for lung delivery with a novel approach to understanding the aerosol performance of …
RC Gopalan, M Najafzadeh, MA Mohammad, D Anderson, A Paradkar, ...
International journal of pharmaceutics 557, 254-263, 2019
292019
Development and validation of micro emulsion high performance liquid chromatography (MELC) method for the determination of nifedipine in pharmaceutical preparation
MKH Al-Jammal, Y Al Ayoub, KH Assi
212015
Aerodynamic dose emission characteristics of dry powder inhalers using an Andersen Cascade Impactor with a mixing inlet: The influence of flow and volume
SI Yakubu, KH Assi, H Chrystyn
International journal of pharmaceutics 455 (1-2), 213-218, 2013
212013
The different resistance of dry powder inhalers (DPIs)
A KH
Am J Respir Crit Care Med 163, A443, 2001
172001
In vitro aerodynamic characterization of the dose emitted during nebulization of tobramycin high strength solution by novel and jet nebulizer delivery systems
M Mashat, BJ Clark, KH Assi, H Chrystyn
Pulmonary Pharmacology & Therapeutics 37, 37-42, 2016
162016
Development and optimisation of inhalable EGCG nano-liposomes as a potential treatment for pulmonary arterial hypertension by implementation of the design of experiments approach
F Haddad, N Mohammed, RC Gopalan, YA Ayoub, MT Nasim, KH Assi
Pharmaceutics 15 (2), 539, 2023
122023
In vitro characterization of the emitted dose from the foradil aerolizer to identify the influence of inhalation flow, inhilation volume and the number of inhalations per dose
A Alaboud, KH Assi, H Chrystyn
Respiratory drug delivery 3, 803-806, 2010
122010
O sistema não pode executar a operação agora. Tente novamente mais tarde.
Artigos 1–20